Company intelligence
CorTec
Fighting neurological conditions with implantable neurotechnology
About CorTec
CorTec is a German clinical-stage neurotechnology company, founded in 2010, with one purpose: to restore independence to people with neurological conditions. We build implantable systems that communicate directly with the nervous system. Our Brain Interchange™ platform, a fully implantable, bidirectional brain-computer interface (BCI), is now in clinical evaluation with patients, opening entirely new treatment modalities while gathering the data that, with AI, unlocks future therapies. We also provide implant technology to others in the global neurotherapy field, so together we can restore independence at a scale none of us could reach alone.
Verified activity
Signals from CorTec
7 published signals
Presence & Recognition
CorTec is attending the Graz Brain-Computer Interface Conference returning for its 10th edition from September 14 to 17.
Reported by CorTec
Products & Services
CorTec launched a new website featuring Brain Interchange™ under the CorTec name, alongside the work on active implants.
Reported by CorTec
Legal & Regulatory
CorTec's implantable brain-computer interface is in clinical evaluation with two FDA Breakthrough Device Designations.
Reported by CorTec
Presence & Recognition
CorTec is live at Medtec China at the Shanghai New International Expo Centre.
Reported by CorTec
Presence & Recognition
CorTec representatives Dr. Oliver Baertl, Fabius Maier, and Benjamin Burg are on-site representing CorTec at Stand 1D301 in the German Pavilion at Medtec China.
Reported by CorTec
Legal & Regulatory
CorTec received a second Breakthrough Device Designation from the FDA for the Brain Interchange system, enabling people with non-progressive quadriplegia to control a computer cursor through thought alone.
Reported by CorTec
Presence & Recognition
CorTec achieved an incredible success with its first steps in the global BCI industry in 2010.
Reported by Ina Saumer